Display Accessibility Tools

Accessibility Tools

Grayscale

Highlight Links

Change Contrast

Increase Text Size

Increase Letter Spacing

Readability Bar

Dyslexia Friendly Font

Increase Cursor Size

MSU Drug Discovery Seminar - Stephanie M. Davis, PhD

SBIR/STTR Funding for Heart, Lung, Blood, and Sleep-Related Biomedical Technologies

 

Abstract: The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR), collectively the Small Business Programs, are also known as America’s Seed Fund. By setting aside more than $1.2 billion from its Research & Development Funding specifically for our Small Business Programs, the NIH provides support to early stage small businesses throughout the nation. Many companies leverage NIH funding to attract the partners and investors needed to take an innovation to market. We focus on a variety of high-impact technologies ranging from research tools, diagnostics, digital health, drugs, medical devices, and others. Dr. Stephanie Davis, the Small Business Program Officer at the National Heart Lung and Blood Institute (NHLBI), will provide an overview of funding opportunities and resources that academic innovators may use to bring their heart, lung, blood, and sleep-related technologies from the bench to the bedside.

Date:  October 25, 2022

Time:  12:00 PM

Location: https://msu.zoom.us/j/98517346580

Passcode:  504326